Header Logo

Connection

FERDINANDOS SKOULIDIS to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications FERDINANDOS SKOULIDIS has written about Clinical Trials, Phase II as Topic.
FERDINANDOS SKOULIDIS
Connection Strength
0.111
Clinical Trials, Phase II as Topic
  1. Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer. Clin Cancer Res. 2017 Feb 01; 23(3):618-622.
    View in: PubMed
    Score: 0.111
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.